(NEJM) Tolebrutinib vs. teriflunomide in relapsing MS on: April 09, 2025, 09:24:54 pm #1 From the New England Journal of Medicine (April 10, 2025)--"Tolebrutinib versus teriflunomide [Aubagio] in relapsing multiple sclerosis":https://www.nejm.org/doi/full/10.1056/NEJMoa2415985?query=TOC&cid=DM2394687_Non_Subscriber&bid=-1400639176Sanofi supported this study. Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
